Share
Market Research Report

HIV CLINICAL TRIALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By PhasePhase I · Phase II · Phase III · Phase IV · and Preclinical
  • By Study DesignInterventional Studies · Observational Studies · and Expanded Access Studies
  • By Sponsor TypePharmaceutical & Biotechnology Companies · Academic Research Institutes · Government & Private Research Organizations · and Contract Research Organizations (CROs)
  • By IndicationHIV-1 and HIV-2
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In02 Apr 2026
  • Report CodeCMI7622
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global HIV Clinical Trials Market, By Phase
      • Global HIV Clinical Trials Market, By Study Design
      • Global HIV Clinical Trials Market, By Sponsor Type
      • Global HIV Clinical Trials Market, By Indication
      • Global HIV Clinical Trials Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Driver
      • Restraint
      • Opportunity
      • Impact Analysis
      • Key Developments
      • Regulatory Scenario
      • Product Launches/Approvals
      • PEST Analysis
      • PORTER’s Analysis
      • Merger and Acquisition Scenario
      • Industry Trends
  4. Global HIV Clinical Trials Market, By Phase, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Phase I
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Phase II
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Phase III
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Phase IV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Preclinical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global HIV Clinical Trials Market, By Study Design, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Interventional Studies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Observational Studies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Expanded Access Studies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global HIV Clinical Trials Market, By Sponsor Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pharmaceutical & Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Academic Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Government & Private Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global HIV Clinical Trials Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • HIV-1
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • HIV-2
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8.  

    Global HIV Clinical Trials Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, By Phase, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Study Design, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Sponsor Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Gilead Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Astellas Pharma Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Vertex Pharmaceuticals Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'HIV Clinical Trials Market' - Global forecast to 2033